Latest autoimmune diseases Stories
Researchers have developed an inexpensive and portable new device that uses nanotechnology to diagnose type-1 diabetes – a breakthrough that they claim could improve patient care worldwide and help medical experts better understand the condition.
An investigational medication shows promise in treating the most common skin disorder, often referred to as eczema or atopic dermatitis.
Strengthens Collaboration between the Nation's Lupus Research Organizations NEW YORK, July 8, 2014 /PRNewswire/ -- The Lupus Research Institute (LRI) today announced that Team
The Autoimmunity Bible & Norton Protocol is a new product created by Julia Liu and is a system designed for people suffering from and wanting to cure for good their autoimmune disorders.
Data presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) showed that a significant number of patients with psoriatic arthritis (PsA) were not receiving doses of the tumour necrosis factor-alpha (TNFα) inhibitor adalimumab necessary to achieve optimal clinical benefit.
A new study presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) showed that, for the majority of lupus patients who are in remission, it is possible to successfully stop immunosuppressant therapy without triggering a flare of their disease.
More than one quarter of children with two copies of a high-risk variant in a specific group of genes develop an early sign of celiac disease called celiac disease autoimmunity (CDA) by age 5.
World Vitiligo Day 2014 promises to be the biggest yet, with a vast array of awareness and support events spanning the globe.
- A woman chauffeur.
- A woman who operates an automobile.